Cogan's syndrome and development of ANCA-associated renal vasculitis after lengthy disease remission

Clin Exp Rheumatol. 2009 Jan-Feb;27(1 Suppl 52):S144.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / complications*
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / immunology
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / pathology
  • Antibodies, Antineutrophil Cytoplasmic / blood*
  • Azathioprine / therapeutic use
  • Cogan Syndrome / complications*
  • Cogan Syndrome / drug therapy
  • Cogan Syndrome / pathology
  • Cyclophosphamide / therapeutic use
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Injections, Intravenous
  • Kidney Diseases / complications*
  • Kidney Diseases / immunology
  • Kidney Diseases / pathology
  • Kidney Glomerulus / pathology
  • Methylprednisolone / therapeutic use
  • Middle Aged
  • Prednisone / therapeutic use
  • Recurrence
  • Remission Induction

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Antineutrophil Cytoplasmic
  • Immunosuppressive Agents
  • Cyclophosphamide
  • Azathioprine
  • Prednisone
  • Methylprednisolone